Cancer incidence before and after kidney transplantation

JAMA

Volumn 296, Issue 23, 2006, Pages 2823-2831

  Vajdic, Claire M ^a   McDonald, Stephen P ^b,c   McCredie, Margaret R E ^d   Van Leeuwen, Marina T ^a   Stewart, John H ^d   Law, Matthew ^a   Chapman, Jeremy R ^b,e   Webster, Angela C ^b,e   Kaldor, John M ^a   Grulich, Andrew E ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d UNIVERSITY OF OTAGO   (New Zealand)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN CANCER; CANCER INCIDENCE; CANCER RISK; CHILD; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; EYE CANCER; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RESPIRATORY TRACT CANCER; SKIN CANCER; UROGENITAL TRACT CANCER;

EID: 33845711356     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.296.23.2823     Document Type: Article

References (31)

1. Kinlen LJ. Immunosuppression and cancer. In: Vainio H, Magee PN, McGregor DB, McMichael AJ, eds. Mechanisms of Carcinogenesis in Risk Identification. Lyon, France: International Agency for Research on Cancer; 1992:237-253.
2. Birkeland SA, Storm JJ, Lamm LU, et al. Cancer risk after renal transplantation in the Nordic countries, 1964-1986. Int J Cancer. 1995;60:183-189.
3. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000;355:1886-1887.
4. McDonald SP, Excell L, eds. ANZDATA Registry Report 2005. Adelaide: Australia and New Zealand Dialysis and Transplant Registry; 2005.
5. International Agency for Research on Cancer (IARC). International Rules for Multiple Primary Cancers (ICD-O Third Edition). Lyon, France: IARC Press; 2004.
6. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer in Australia 2001. Canberra: Australian Institute of Health and Welfare; 2004. AIHW Cat. No. CAN 23. Cancer Series; No. 28.
7. Jaro MA. Probabalistic linkage of large public health data files. Stat Med. 1995;14:491-498.
8. Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS. 1999;13:839-843.
9. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92:1500-1510.
10. Li Y, Law M, McDonald A, Correll P, Kaldor JM, Grulich AE. Estimation of risk of cancers before occurrence of acquired immunodeficiency syndrome in persons infected with human immunodeficiency virus. Am J Epidemiol. 2002;155:153-158.
11. Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR). Cancer Survival in Australia, 2001, Part 2: Statistical Tables. Canberra: Australian Institute of Health and Welfare; 2001. AIHW Cat. No. CAN 14. Cancer Series; No. 19.
12. South Australian Cancer Registry. Epidemiology of Cancer in South Australia. Adelaide: South Australian Cancer Registry; 2000.
13. World Health Organization. International Statistical Classification of Diseases, 10th Revision (ICD-10). Geneva, Switzerland: World Health Organization; 1992.
14. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Hepatitis Viruses, Volume 59. Lyon, France: IARC Press; 1994.
15. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Immunodeficiency Viruses and Human T-cell Lymphotropic Viruses, Volume 67. Lyon, France: IARC Press; 1996.
16. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8, Volume 70. Lyon, France: IARC Press; 1997.
17. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses, Volume 64. Lyon, France: IARC Press; 1995.
18. Cogliano V, Baan R, Straif K, et al; WHO International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204.
19. Goldblum SE, Reed WP. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med. 1980;93:597-613.
20. Girndt M, Sester M, Sester U, Kaul H, Kohler H. Molecular aspects of T- and B-cell function in uremia. Kidney Int. 2001;59(suppl 78):S206-S211.
21. Winkelspecht B, Mueller-Lantzsch N, Kohler H. Serological evidence for reactivation of EBV infection due to uraemic immunodeficiency. Nephrol Dial Transplant. 1997;12:2099-2104.
22. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM. Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis. 1989;14:119-123.
23. Vamvakas S, Bahner U, Heidland A. Cancer in end-stage renal disease: potential factors involved. Am J Nephrol. 1998;18:89-95.
24. Shaib Y, el-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115-125.
25. International Agency for Research on Cancer (IARC). IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Schistosomes, Liver Flukes and Helicobacter pylori, Volume 61. Lyon, France: IARC Press; 1994.
26. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. Oxford, England: Oxford University Press; 2006:686-687.
27. Mitsuishi T, Ohara K, Kawashima M, Kobayashi S, Kawana S. Prevalence of human papillomavirus DNA sequences in verrucous carcinoma of the lip: genomic and therapeutic approaches. Cancer Lett. 2005;222:139-143.
28. Grulich AE, Li Y, McDonald A, Correll PK, Law MG, Kaldor JM. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 2002;16:1155-1161.
29. Grulich AE, Wan X, Coates M, Day P, Kaldor JM. Validation of a non-identifying method of linking cancer and AIDS register data. J Epidemiol Biostat. 1996;1:207-212.
30. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, eds. Cancer Incidence in Five Continents, Volume VIII. Lyon, France: IARC Press; 2002. IARC Scientific Publication No. 155.
31. Australian Institute of Health and Welfare. 2004 National Drug Strategy Household Survey: First Results. Canberra: Australian Institute of Health and Welfare; 2005. AIHW Cat. No. PHE 57.